Track Every Presidential Action. Understand the Impact.
AI-powered summaries of executive orders, proclamations, and memoranda.
Type
Ensuring Truthful Advertising of Products Claiming To Be Made in America
On March 13, 2026, President Donald Trump issued Executive Order 14392, aimed at ensuring truthful advertising of products claiming to be "Made in America." This order directs the Federal Trade Commission (FTC) to prioritize enforcement against misleading claims about American-origin products, particularly in digital marketplaces. It also encourages the FTC to consider regulations that would require online marketplaces to verify country-of-origin claims. Additionally, the order prompts government agencies to review and verify American-origin claims in government contracts and to take action against vendors who misrepresent these claims. The goal is to protect consumers and support businesses genuinely manufacturing products in the United States.
Stay up to date on presidential actions
New executive orders and proclamations, straight to your inbox.
Feb 25, 2026
FRContinuing the Suspension of Duty-Free De Minimis Treatment for All Countries
Nov 07, 2025
FRModifying Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
Aug 06, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border
On July 31, 2025, President Donald Trump issued Executive Order 14325 to amend duties in response to the flow of illicit drugs across the U.S.-Canada border. This order increases the additional ad valorem duty rate on certain Canadian products from 25% to 35% as part of ongoing efforts to address a national emergency related to drug trafficking, particularly fentanyl. The order also outlines measures to prevent transshipment and mandates the monitoring of Canada's cooperation in combating drug trafficking. The changes are effective for goods entered for consumption on or after August 1, 2025, and aim to pressure Canada to take more substantial action against drug trafficking organizations.
Aug 05, 2025
FRSuspending Duty-Free De Minimis Treatment for All Countries
On July 30, 2025, President Donald Trump issued Executive Order 14324, suspending the duty-free de minimis treatment for imports from all countries. This action means that low-value shipments, which previously entered the U.S. without duties, will now be subject to applicable tariffs, taxes, and fees. The order was issued to address national emergencies related to drug trafficking and trade imbalances, ensuring that tariffs effectively counter these threats. The suspension applies to shipments not covered by specific exemptions, with a focus on enhancing the collection of duties and preventing evasion through deceptive shipping practices. The order directs the Department of Homeland Security to implement necessary measures for its enforcement.
Jul 31, 2025
Amendment to Duties to Address the Flow of Illicit Drugs Across Our Northern Border
President Donald Trump issued an amendment to increase tariffs on certain Canadian goods in response to Canada's insufficient efforts to curb the flow of illicit drugs, such as fentanyl, across the northern border. This action raises the additional tariff rate from 25% to 35% on specific Canadian products, effective August 1, 2025. The amendment also targets transshipped goods from Canada, imposing a 40% tariff on those that do not qualify under the USMCA. The order aims to pressure Canada into taking more robust measures against drug trafficking and to address any retaliatory actions from Canada.
Apr 07, 2025
FRFurther Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China as Applied to Low-Value Imports
On April 2, 2025, President Donald Trump issued Executive Order 14256, which amends duties on low-value imports from the People's Republic of China (PRC) to combat the synthetic opioid crisis. This order eliminates the duty-free de minimis exemption for certain low-value products from China and Hong Kong, requiring these imports to be subject to duties when they enter the United States after May 2, 2025. The order mandates that U.S. Customs and Border Protection (CBP) collect these duties and allows for either a 30% ad valorem duty or a specific duty of $25 or $50 per item, depending on the date of entry. This action aims to address deceptive shipping practices that facilitate the entry of illicit substances into the U.S. while maintaining the flow of legitimate international mail.
Apr 02, 2025
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China as Applied to Low-Value Imports
President Donald Trump issued an order to amend duties on low-value imports from the People's Republic of China (PRC), including Hong Kong, to address the synthetic opioid crisis. The order eliminates the duty-free treatment for certain low-value shipments, which previously benefited from the *de minimis* exemption, effective May 2, 2025. Shipments valued at $800 or less will now be subject to additional duties, with specific rates applied to postal items. This action aims to curb deceptive shipping practices that contribute to the opioid crisis by ensuring that duties are collected on these imports. The Secretary of Homeland Security is tasked with implementing the order, and a report on its impact is expected within 90 days.
Mar 11, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Northern Border
President Donald Trump issued Executive Order 14231 on March 6, 2025, to amend tariffs related to the flow of illicit drugs across the northern border. This order adjusts duties initially imposed in a previous executive order, specifically exempting Canadian automotive parts and components from additional tariffs to support the U.S. automotive industry. It also reduces the tariff on potash from 25% to 10% for certain imports. The changes aim to minimize disruption to the automotive sector while addressing drug flow concerns.
Mar 11, 2025
FRAmendment to Duties To Address the Flow of Illicit Drugs Across Our Southern Border
On March 6, 2025, President Donald Trump issued Executive Order 14232 to amend tariffs related to the flow of illicit drugs across the U.S. southern border. This order adjusts the duties imposed on certain goods from Mexico, specifically exempting automotive parts and components from additional tariffs to support the U.S. automotive industry. Additionally, the tariff on potash not covered by these exemptions is reduced from 25% to 10%. These changes aim to minimize disruptions to the automotive sector while addressing border security concerns.
Mar 07, 2025
FRFurther Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
President Donald Trump issued Executive Order 14228 on March 3, 2025, which amends a previous order to address the synthetic opioid supply chain originating from the People's Republic of China. The order increases tariffs from 10 percent to 20 percent on certain Chinese products as a response to China's inadequate efforts to curb the flow of synthetic opioids, such as fentanyl, into the United States. This action is taken under the authority of the International Emergency Economic Powers Act and aims to pressure China into taking more effective measures against the opioid crisis that poses a threat to U.S. national security, foreign policy, and economy.
Mar 06, 2025
Amendment to Duties to Address the Flow of Illicit Drugs Across Our Southern Border
President Donald Trump issued an amendment to adjust tariffs related to the flow of illicit drugs across the U.S.-Mexico border. This action modifies the tariffs imposed by a previous executive order to minimize disruption to the U.S. automotive industry, which heavily relies on cross-border trade of automotive parts. Specifically, goods from Mexico that are duty-free under certain trade agreements will not face additional tariffs, and the tariff on potash will be reduced from 25% to 10%. These changes take effect on March 7, 2025.
Mar 03, 2025
Further Amendment to Duties Addressing the Synthetic Opioid Supply Chain in the People’s Republic of China
On March 3, 2025, President Donald Trump issued an order to amend existing tariffs related to the synthetic opioid supply chain from the People’s Republic of China. This amendment increases the previously established tariff rate from 10 percent to 20 percent on certain Chinese products. The decision was made because China has not taken sufficient action to address the flow of synthetic opioids, such as fentanyl, into the United States, which poses a significant threat to U.S. national security and economy. The order aims to pressure China into cooperating more effectively in combating the illicit drug crisis.
Mar 02, 2025
Amendment to Duties to Address the Flow of Illicit Drugs across our Northern Border
President Donald Trump issued an amendment to existing executive orders concerning the flow of illicit drugs across the U.S.-Canada border. This amendment modifies the duty-free de minimis treatment for certain goods, allowing it only until the Secretary of Commerce confirms that systems are in place to efficiently collect applicable tariff revenues. The amendment aims to tighten control over goods entering the U.S. to better address drug trafficking issues. It clarifies that the order does not affect existing legal authorities or create enforceable rights against the government.
Mar 02, 2025
Amendment to Duties to Address the Situation at our Southern Border
President Donald Trump issued an amendment to existing executive orders concerning duties at the U.S. southern border. This amendment modifies the conditions under which certain articles can receive duty-free treatment. Specifically, it states that duty-free treatment will no longer be available once the Secretary of Commerce confirms that systems are in place to efficiently process and collect applicable tariffs. The order clarifies that it does not alter the authority of any executive department or agency and must be implemented according to existing laws and budget constraints.
Feb 11, 2025
FRAmendment to Duties Addressing the Synthetic Opioid Supply Chain in the People's Republic of China
On February 5, 2025, President Donald Trump issued Executive Order 14200, amending a previous order related to the synthetic opioid supply chain in China. This amendment focuses on the duty-free de minimis treatment for certain articles, specifying that this treatment will end once the Secretary of Commerce confirms that systems are in place to efficiently process and collect applicable tariffs. The order aims to enhance the U.S. government's ability to manage and collect revenue from tariffs on goods linked to the synthetic opioid supply chain from China. The order is to be implemented in accordance with existing laws and available funding.